✦ LIBER ✦

Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer

✍ Scribed by Michael J. Millward; Adrian L. Harris; Brian M. J. Cantwell

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 429 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900601)65:11<2421::aid-cncr2820651103>3.0.co;2-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of peptichemio in advan

A phase II study of peptichemio in advanced breast cancer

✍ V. Hug; G. N. Hortobagyi; A. U. Buzdar; G. R. Blumenschein; W. Grose; M. A. Burg 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

Phase II study of a modified combination

Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer

✍ Içli, Fikri; Karaoguz, Handan; Akbulut, Hakan; Dinçol, Dilek; Demirkazik, Ahmet; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

## Background: Based on the promising results of eap (etoposide, doxorubicin, and cisplatin) combination, a phase ii study of modified eap combination was performed in patients with advanced gastric cancer to evaluate the response, toxicity, and survival. ## Method: Fifty-two consecutive patients

A southwest oncology group and cancer an

A southwest oncology group and cancer and leukemia group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in Adults with advanced osteosarcoma, ewing's sarcoma, and rhabdomyosarcoma

✍ Karen Antman; John Crowley; Stanley P. Balcerzak; Raymond A. Kempf; Raymond B. W 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

sarcoma, or osteosarcoma. ## Results . Between 1987-1991, 81 patients were entered; 69 patients were eligible.

Phase II trial of gemcitabine in patient

Phase II trial of gemcitabine in patients with advanced gastric cancer

✍ Kathy Christman; David Kelsen; Leonard Saltz; Peter G. Tarassoff 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 2 views

Phase II study of gemcitabine in patient

Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Tai-Shen Yang; Yung-Chang Lin; Jen-Shi Chen; Hung-Ming Wang; Chen-Hsu Wang 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

A phase II study of piritrexim in patien

A phase II study of piritrexim in patients with advanced squamous head and neck cancer

✍ Wu-Ching Uen; Andrew T. Huang; Robert Mennel; Stephen E. Jones; Monica B. Spauld 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the